Skip to content

Probing the Catalytic Promiscuity and Enhancing the Efficiency of CYP725A4 with a Taxadiene Substrate Mimic

Aug 2026 · ACS Catalysis · 0 citations · 86 references

Abstract

The catalytic promiscuity of cytochrome P450 CYP725A4 severely impedes paclitaxel biosynthesis, as it generates taxadien-5α-ol (T-5α-ol) alongside numerous by-products. Despite diverse proposed mechanisms and the reported role of facilitator of taxane oxidation (FoTO1) in promoting T-5α-ol formation, conclusive evidence elucidating the catalytic promiscuity of CYP725A4 remains elusive. Here, we report a substrate mimic strategy using taxadien-2-one (taxadienone), which is selectively epoxidized by CYP725A4 at the C4=C5 double bond, suggesting epoxidation as its major catalytic pathway. This notion was then confirmed by the successful identification of the long-observed yet structurally uncharacterized major taxadiene oxidation product as 4(5)α-epoxy-taxadiene, which can spontaneously rearrange in solution. Furthermore, the minor T-5α-ol produced by CYP725A4 arises from a concurrent hydroxylation pathway rather than from epoxidation, and efficient isomerization of 4(5)α-epoxy-taxadiene to T-5α-ol by FoTO1 is required to achieve improved product selectivity. Employing the promiscuity-free taxadienone as a probe substrate eliminated analytical complications and led to variant M3, which shows markedly enhanced catalytic activity through optimized heme-binding and enhanced FG loop flexibility. Finally, co-expressing the plant-derived FoTO1 with the CYP725A4 variant M3 in engineered Escherichia coli increased T-5α-ol production to 109.1 mg/L in a 5 L bioreactor. Collectively, this strategy provides crucial insights into CYP725A4 catalytic promiscuity and enables more efficient directed evolution, thereby facilitating downstream paclitaxel pathway optimization.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.